Algone DFW Interventional Pain to Offer New Non-Invasive Ablation Treatment

Texas clinic to be first in the state to use Neurolyser XR device for chronic back pain

Apr. 5, 2026 at 11:19am

Got story updates? Submit your updates here. ›

Algone DFW Interventional Pain in McKinney, Texas will be the first medical practice in the state to offer the new Neurolyser XR non-invasive ablation treatment for chronic low back pain. The Neurolyser XR uses high-intensity focused ultrasound (HIFU) to perform nerve ablation without the need for needles or invasive procedures, providing patients a minimally-invasive option for long-term pain relief.

Why it matters

The introduction of the Neurolyser XR represents a significant advancement in pain management, as it allows clinicians to precisely target and treat nerve-related conditions without the risks and discomfort associated with traditional invasive procedures. This new technology has the potential to improve patient outcomes, reduce reliance on opioids, and accelerate recovery times.

The details

Prior to the Neurolyser XR, ablation of the medial branch nerves in the lumbar area was commonly performed using an invasive process that required needles to be placed into the back near the vertebrae. The Neurolyser XR eliminates the need for needles by using a non-invasive focused ultrasonic beam to perform the ablation. This new approach provides the same therapeutic benefits as the traditional method, but with a much less invasive procedure.

  • Algone DFW Interventional Pain will begin treating patients with the Neurolyser XR on Tuesday, April 7, 2026.
  • The Neurolyser XR received FDA DeNovo approval in November 2025.

The players

Algone DFW Interventional Pain

A leading interventional pain care practice in McKinney, Texas that is the first in the state to offer the Neurolyser XR non-invasive ablation treatment.

FUSMobile, Inc.

The company that developed the Neurolyser XR device, which uses high-intensity focused ultrasound (HIFU) to perform nerve ablation without the need for needles or invasive procedures.

Dr. Shamsideen Musa

The physician at Algone DFW Interventional Pain who will be the first in Texas to begin treating patients with the Neurolyser XR.

Bruce Taylor

The North America Sales Manager for FUSMobile, the company that developed the Neurolyser XR.

Dr. Arik Hananel

The co-founder of FUSMobile who developed the Neurolyser XR device.

Got photos? Submit your photos here. ›

What they’re saying

“I am proud to be the first to bring this new revolutionary treatment to Texas. We at Algone DFW Interventional Pain like to be on the leading edge of medicine.”

— Dr. Shamsideen Musa, Physician, Algone DFW Interventional Pain

“Most patients prefer to not have needles when given the option. We look forward to bringing this technology to many more clinics.”

— Bruce Taylor, North America Sales Manager, FUSMobile

“The future of medicine is non-invasive treatments, FUSMobile is proud to be leading the way into new methods of treatment.”

— Dr. Arik Hananel, Co-Founder, FUSMobile

What’s next

Algone DFW Interventional Pain will begin treating patients with the Neurolyser XR on Tuesday, April 7, 2026. The clinic is welcoming media to attend and see the device in action.

The takeaway

The introduction of the Neurolyser XR at Algone DFW Interventional Pain represents a significant advancement in pain management, offering patients a minimally-invasive option for long-term relief of chronic low back pain. This new technology has the potential to improve outcomes, reduce reliance on opioids, and set a new standard for non-invasive patient care.